3,5-dihydroxystilbene
inhibits the diphenolase activity of mushroom tyrosinase; structure in first source
Networked: 2
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
| 1. | Hewitt, L Mark:
1 article
(01/2011)
|
| 2. | Kohli, Jagmohan:
1 article
(01/2011)
|
| 3. | Parrott, Joanne L:
1 article
(01/2011)
|
| 4. | Sherry, James P:
1 article
(01/2011)
|
| 5. | Albanito, Lidia:
1 article
(07/2009)
|
| 6. | Andò, Sebastiano:
1 article
(07/2009)
|
| 7. | Dolce, Vincenza:
1 article
(07/2009)
|
| 8. | Forti, Luca:
1 article
(07/2009)
|
| 9. | Gabriele, Bartolo:
1 article
(07/2009)
|
| 10. | Iacopetta, Domenico:
1 article
(07/2009)
|
Related Diseases
| 1. | Hepatocellular Carcinoma (Hepatoma)
|
| 2. | Breast Neoplasms (Breast Cancer)
07/01/2009
- " We assessed structure-activity relationships of RSV and the analogs 4,4'-dihydroxystilbene (4,4'-DHS), 3,5-dihydroxystilbene (3,5-DHS), 3,4'-dihydroxystilbene (3,4'-DHS), 4-hydroxystilbene (4-HS) using as model systems the ERalpha-positive and negative MCF7 and SkBr3 breast cancer cells, respectively. "
|
|
Related Drugs and Biologics